About Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Clinical Trials at Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1
During the past decade, Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1 conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1"
#1 collaborator was "ADIR, a Servier Group company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1
According to Clinical.Site data, the most researched conditions in "Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1" are
"Metastatic Colorectal Cancer" (2 trials). Many other conditions were trialed in "Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1" in a lesser frequency.
Clinical Trials Intervention Types at Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1
Most popular intervention types in "Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab control" (1 trials), "Bevacizumab experimental" (1 trials), "Capecitabine" (1 trials), "Trifluridine/Tipiracil hydrochloride (S95005)" (1 trials) and "Trifluridine/tipiracil hydrochloride (S95005)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1
The vast majority of trials in "Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1" are
2 trials for "All" genders.
Clinical Trials Status at Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1
Currently, there are NaN active trials in "Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Istituto Oncologico Veneto IOV - IRCCS Unità Operativa Complessa Oncologia Medica 1, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".